California Picture - California Photography
California Picture is a collection of art photography and art photographic prints of California scenic views and wildlife.

Today announced completion of a $13 million Series C funding.

CeNeRx BioPharma raises $13 million through Series C funding to support TriRima Phase II trial CeNeRx BioPharma, Inc., a clinical stage firm developing and commercializing innovative treatments for diseases of the central nervous program , today announced completion of a $13 million Series C funding. ‘These money will support the Phase II trial of TriRima as monotherapy for treatment-resistant depression,’ said Barry Brand, Chief Executive Officer of CeNeRx.’ Related StoriesEstradiol fluctuation may enhance psychological sensitivity to psychosocial stress during menopausal transitionUCLA launches second Grand Challenge to reduce health insurance and financial impacts of depressionComputerised cognitive behavioural therapy likely to be ineffective in major depression treatmentCeNeRx is preparing to conduct a Phase II trial with an improved formulation of its business lead product applicant TriRima for treatment-resistant melancholy..Related StoriesCombatting viral and bacterial lung attacks with volatile anesthetics: an interview with Dr ChakravarthyRaising lupus consciousness: an interview with Professor Ramsey-Goldman, MDAddressing standard of living needs in prostate tumor: an interview with Professor Louis DenisDr. Piovesan, from Medical center de Clinicas da Universidade Federal government perform Parana in Curitiba, Brazil, and co-workers gave subcutaneous shots of botulinum toxin to four guys who got trigeminal neuralgia for typically 10 years also to nine ladies who had suffered typically for 8 years. The patients assessed the discomfort in the three branches of the trigeminal nerve on a 10-stage visible analog scale, which ranged from 9.82 to 10 factors before treatment.